home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Genetic News | search  
 

Feeding Back on Tumour Initiation

 
  December, 11 2009 9:26
your information resource in human molecular genetics
 
     
The protein ZEB1 -- which is known to promote invasiveness of epithelial tumours -- also influences the tumour initiating capacity of pancreatic and colorectal cancer cells, and could possibly promote cancerous cells proliferation once they have reached a new organ. The finding, published online in Nature Cell Biology, suggests that targeting a feedback loop in which ZEB1 is involved in might represent a promising avenue for the treatment of certain cancers.

The small RNAs of the miR200 family were previously reported to inhibit cell invasion and movement of certain cancerous tissues via direct inhibition of ZEB1. ZEB1 in turn suppresses the expression of miR200. Thomas Brabletz and colleagues now show that miR200 also inhibits various factors required for the maintenance of stem cells characteristics, including factors that promote self-renewal, proliferation and inhibit differentiation. They also demonstrate that loss of ZEB1 in human pancreatic cancer cell lines reduces their tumour initiation potential by suppressing miR200-dependent inhibition of stem cells factors. By examining primary pancreatic cancer tissues of mouse and human origins, they show that less differentiated tumours express high levels of ZEB1 and stem cell factors, while tumours isolated from patients that are long term survivors of pancreatic cancers have low ZEB1.

This study suggests that ZEB1 promotes both tumour spread and initiation by enhancing the stem cells characteristics of the cells that migrate away from the primary tumour to form metastases.

Author contact:

Thomas Brabletz (University of Freiburg, Germany)
E-mail: thomas.brabletz@uniklinik-freiburg.de

Abstract available online.

(C) Nature Cell Biology press release.


Message posted by: Trevor M. D'Souza

print this article mail this article
Bookmark and Share this page (what is this?)

Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.

Use the links below to share this article on the social bookmarking site of your choice.

Read more about social bookmarking at Wikipedia - Social Bookmarking

Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2017 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.